Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Karabelas Argeris N
Relationship:  
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   7    
Direct Shares   130,211    

Indirect Shares

   3,405,909      
Direct Value   $981,332    

Indirect Value

   $53,877,109      
Total Shares   3,536,120      
Total Value   $54,858,441      


Bausch Health Companies Inc $875,902 Regenxbio Inc. $105,430 Bausch Health Companies Inc $875,902 Regenxbio Inc. $105,430
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Anadys Pharmaceuticals Inc ANDS Director 0 2004-03-18 1,128,770    Premium*  
            Vanda Pharmaceuticals Inc. VNDA Director 0 2010-03-12 0    Premium*  
            Biodelivery Sciences Internation... BDSI 10% Owner 2009-06-17 0 2009-07-16 0    Premium*  
            Human Genome Sciences Inc HGSI Director 2012-07-30 0 2006-11-10 0    Premium*  
            Rocket Pharmaceuticals RCKT Director, 10% Owner 0 2015-02-23 2,277,139    Premium*  
            Bausch Health Companies Inc BHC Director 2022-06-24 123,715 2016-06-17 0    Premium*  
            Regenxbio Inc. RGNX 2023-06-02 6,496 2022-06-03 0    Premium*  
* Premium Members only  

Records found :    66         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ANDS Anadys Pharmaceuticals In... Director   –       •      –    2004-03-18 3 IO $0.00 $0 I/I 0 1,128,770 -
VNDA Vanda Pharmaceuticals Inc... Chairman of the BoardOfficer   •       •      –    2006-04-12 3 IO $0.00 $0 I/I 0 1,540 -
VNDA Vanda Pharmaceuticals Inc... Chairman of the Board   •       •      –    2006-04-18 4 A $0.00 $0 I/I 3,612,665 232,000 -
HGSI Human Genome Sciences Inc Director   –       •      –    2006-11-10 4 B $12.15 $151,875 D/D 12,500 12,500 2.39 -
VNDA Vanda Pharmaceuticals Inc... Chairman of the Board   •       •      –    2006-11-17 4/A S $14.25 $3,847,500 I/I (270,000) 214,666 0 -
VNDA Vanda Pharmaceuticals Inc... Chairman of the Board   •       •      –    2006-11-17 4 S $14.25 $3,847,500 I/I (270,000) 313,705 0 -
VNDA Vanda Pharmaceuticals Inc... Chairman of the Board   •       •      –    2006-11-20 4 S $15.29 $764,500 I/I (50,000) 310,495 0 -
VNDA Vanda Pharmaceuticals Inc... Chairman of the Board   •       •      –    2006-11-20 4/A S $15.29 $764,500 I/I (50,000) 211,456 0 -
VNDA Vanda Pharmaceuticals Inc... Chairman of the Board   •       •      –    2006-11-21 4 S $14.55 $727,500 I/I (50,000) 208,246 0 -
VNDA Vanda Pharmaceuticals Inc... Chairman of the Board   •       •      –    2006-11-22 4 S $14.12 $4,236,000 I/I (300,000) 188,986 0 -
VNDA Vanda Pharmaceuticals Inc... Chairman of the Board   •       •      –    2006-11-27 4 S $14.18 $4,254,000 I/I (300,000) 169,726 0 -
VNDA Vanda Pharmaceuticals Inc... Chairman of the Board   •       •      –    2006-12-11 4 S $26.40 $8,614,980 I/I (326,325) 148,776 0 -
VNDA Vanda Pharmaceuticals Inc... Chairman of the Board   •       •      –    2006-12-12 4 S $25.18 $10,680,097 I/I (424,150) 121,546 0 -
VNDA Vanda Pharmaceuticals Inc... Director   –       •      –    2007-02-20 4 S $27.37 $5,474,360 I/I (200,000) 108,706 0 -
VNDA Vanda Pharmaceuticals Inc... Director   –       •      –    2007-02-21 4 S $26.74 $6,337,380 I/I (237,000) 93,491 0 -
VNDA Vanda Pharmaceuticals Inc... Director   –       •      –    2007-02-22 4 S $26.82 $1,947,328 I/I (72,600) 88,830 0 -
VNDA Vanda Pharmaceuticals Inc... Director   –       •      –    2007-02-23 4 S $26.02 $9,993,757 I/I (384,130) 64,169 0 -
BDSI Biodelivery Sciences Inte... 10% Owner   –       –       •   2009-06-17 4 S $6.40 $640,180 I/I (100,000) 1,295,000 0 -
BDSI Biodelivery Sciences Inte... 10% Owner   –       –       •   2009-06-18 4 S $6.50 $412,219 I/I (63,391) 1,231,609 0 -
BDSI Biodelivery Sciences Inte... 10% Owner   –       –       •   2009-06-19 4 S $6.54 $723,515 I/I (110,614) 1,120,995 0 -
BDSI Biodelivery Sciences Inte... 10% Owner   –       –       •   2009-06-22 4 S $6.56 $76,433 I/I (11,657) 1,109,338 0 -
BDSI Biodelivery Sciences Inte... 10% Owner   –       –       •   2009-06-23 4 S $6.30 $206,758 I/I (32,800) 1,076,538 0 -
BDSI Biodelivery Sciences Inte... 10% Owner   –       –       •   2009-06-24 4 S $6.48 $81,423 I/I (12,559) 1,063,979 0 -
BDSI Biodelivery Sciences Inte... 10% Owner   –       –       •   2009-06-25 4 S $6.51 $253,498 I/I (38,965) 1,025,014 0 -
BDSI Biodelivery Sciences Inte... 10% Owner   –       –       •   2009-06-26 4 S $6.85 $3,273,181 I/I (477,509) 547,505 0 -
  66  Records found
  1  2   3      
  Page 1 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us